Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02448303 |
|---|---|
| Brief Title: | Pembrolizumab Alone and In Combination With Acalabrutinib (ACP-196) in Subjects With Advanced Non-small Cell Lung Cancer (KEYNOTE166) |
| First Submitted : | May 14, 2015 |
| First Submitted that Met QC Criteria : | May 15, 2015 |
| First Posted : | May 19, 2015 (Estimate) |
| Results First Submitted : | July 19, 2019 |
| Results First Submitted that Met QC Criteria : | August 22, 2019 |
| Results First Posted : | September 12, 2019 |
| Last Update Submitted that Met QC Criteria : | August 22, 2019 |
| Last Update Posted : | September 12, 2019 |